🇺🇸 FDA
Patent

US 12325688

Gingerenone A prodrugs as sensotherapeutics and methods of use

granted A61KA61K31/232A61K47/542

Quick answer

US patent 12325688 (Gingerenone A prodrugs as sensotherapeutics and methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jun 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/232, A61K47/542, A61P, A61P25/28